Protein Engineering Market
Global Protein Engineering Market Size, Share & Trends Analysis Report by Technology (Rational Protein Design and Irrational Protein Design), by Protein Type (Monoclonal Antibodies, Insulin, Erythropoietin, Interferon, Colony Stimulating Factor, Coagulation Factor, Vaccines, and Others), By Product (Instruments, Services and Software, and Reagents), and by End-User (Academic Research Institutes, Pharmaceutical, and Biotechnology Companies, and Contract Research Organizations), and Forecast 2022-2028 Update Available - Forecast 2024-2030
The global protein engineering market is anticipated to grow at a significant CAGR of around 12.5% during the forecast period (2022-2028). Protein engineering holds an immense opportunity in the agrochemical industry as engineering in proteins may lead to the generation of enzymes with an improved function that may increase the crop yield or facilitate biofuel production. It is also likely to play an important role as a tool to attain increased crop yield needed to meet future needs. Some methods are used for protein engineering such as site-directed mutagenesis, random mutagenesis, random mutagenesis, homology modeling, cell surface display technology, and DNA shuffling technology. Protein engineering has various applications as biocatalysts from medical, environmental to nanobiotechnology. The rising focus of pharmaceutical and biotechnology companies on research & development of protein-based drugs due to advantages over non-protein drugs, such as higher cost-effectiveness and improved patient outcomes are the major factors driving the market growth.
Moreover, the surging strategic collaborations among prominent players of market is another key factor for the market development. For instance, in Jan 2021 Zymvol Biomodeling, S.L collaborated with Aminoverse B.V, a biotech company specializing in enzyme discovery and design, to develop custom-made alcohol dehydrogenases, an enzyme most commonly used in the flavors and fragrances and the fine chemicals industry. Apart from these, increasing public and private investments in synthetic biology, and continuous advancements in protein engineering technologies are expected to offer new growth opportunities to the market during the forecast period.
Impact of COVID-19 Pandemic on Global Protein Engineering Market
The field of protein engineering is widely driven by research. For instance, amid COVID-19 pandemic, in March 2020, a team of scientists from North America found out that Protein mapping finds 69 potential treatments for COVID-19.
Segmental Outlook
The global protein engineering market is segmented based on protein type, product, and end-user. Based on technology, the market is sub-segmented into rational protein design and irrational protein design. Based on protein type, the market is sub-segmented into monoclonal antibodies, insulin, erythropoietin, interferon, colony-stimulating factor, coagulation factor, vaccines, and others. Among these, monoclonal antibodies segment is projected to register the fastest revenue growth rate in the global market over the projected period owing to the increasing R&D activities for advanced monoclonal antibodies. Based on product, the market is sub-segmented into instruments, service and software, and reagents. Based on end-user, the market is sub-segmented into academic research institutes, pharmaceutical and biotechnology companies, and CROs.
Global Protein Engineering Market Share by Protein Type, 2021 (%)
Monoclonal Antibodies segment is expected to be the largest contributor in the global protein engineering market
Monoclonal antibodies are anticipated to hold the largest share over the forecast period owing to their high adoption for numerous therapies such as cancer and autoimmune diseases. The increasing prevalence of cancer and other autoimmune diseases has significantly increased the use of monoclonal bodies for the treatment of diseases. They also have tremendous applications in the fields of therapeutics, diagnostics, and targeted drug delivery systems for infectious diseases caused by viruses, bacteria, protozoa, and many more. Hence, recombinant deoxyribonucleic acid technology, through genetic engineering, has successfully led to the possibility of the reconstruction of monoclonal antibodies, which is the driving factor for the growth of the market.
Regional Outlook
The global protein engineering market is further segmented based on geography including North America (the US and Canada), Europe (Italy, Spain, Germany, France, Rest of Europe), Asia Pacific (India, China, Japan, South Korea, Rest of Asia Pacific), and the Rest of the World (Latin America and the Middle East and Africa).
Global Protein Engineering Market, by Region 2022-2028
The Asia-Pacific region is estimated to hold a major share in the Global Protein Engineering Market
Asia-Pacific is expected to witness the fastest CAGR during the forecast period, due to the growing presence of contract research organizations, rising healthcare IT spending, and unprecedented evolution of the healthcare infrastructure and standards across the region. Growing demand for personalized medicine and strong R&D investments in proteomics-based drug discovery projects are also supplementing the growth of the protein engineering market. In addition, proteomics R&D initiatives coupled with significant funding for protein-based drug research and advancements in genomics in several Asia Pacific countries are likely to offer new growth opportunities to the market during the forecast period.
Major Players Outlooks
The major companies serving the global protein engineering market include AB SCIEX, LLC, Agilent Technologies, Inc, Bio-Rad Laboratories, Inc, Waters Corp., GenScript Biotech Corp, Thermo Fisher Scientific Inc, General Electric Co, Eli Lilly and Co, and Novartis International AG and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches to stay competitive in the market. For instance, in January 2019, Amunix Pharmaceuticals Inc., a biopharmaceutical company focused on the discovery and development of novel mmune-oncology therapeutics entered into a licensing agreement with Merck for rights to develop therapeutics against an undisclosed target using Amunix’s proprietary protease-triggered immune activator (ProTIA) technology platform. The powerful new platform technology enabled the rapid generation of tumor activatable cytokines, signaling peptides/proteins or immune cell engagers.
The report covers
- Market value data analysis of 2022 and forecast to 2028
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global protein engineering market
- Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Protein Engineering Market
1.1. Recovery Scenario of Global Protein Engineering Market
1.2. Research Methods and Tools
1.3. Market Breakdown
1.3.1. By Segments
1.3.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Danaher Corporation
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Agilent Technologies
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Thermo Fisher Scientific Inc
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Bio-Rad Laboratories
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Eli Lily and Co
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
Global Protein Engineering Market by Protein Type
4.1.1. Monoclonal Antibodies
4.1.2. Insulin
4.1.3. Erythropoietin
4.1.4. Interferon
4.1.5. Colony Stimulating Factor
4.1.6. Coagulation Factor
4.1.7. Vaccines
4.1.8. Others (Growth Hormones)
Global Protein Engineering Market by Product
4.1.9. Instruments
4.1.10. Service and Software
4.1.11. Reagents
Global Protein Engineering Market by End-User
4.1.12 Academic Research Institutes
4.1.13 Pharmaceutical and Biotechnology Companies
4.1.14 Contract Research Organizations (CROs)
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
5.4.1 Latin America
5.4.2 Middle East and Africa
6. Company Profiles
6.1. Abbott Laboratories
6.2. AB SIEX, LLC
6.3. Agilent Technologies
6.4. Biogen Inc
6.5. Bio-Rad Laboratories
6.6. Bruker Corporation
6.7. Codexis, Inc.
6.8. GE HealthcareMerck KGaA
6.9. Sanofi SA
6.10. General Electric Co
6.11. Genscript Biotech Corporation
6.12. Bruker Corp
6.13. Novartis International AG
6.14. Novo Nordisk
6.15. Waters Corporation
1. GLOBAL PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY PROTEIN TYPE, 2021-2028 ($ MILLION)
2. GLOBAL MONOCLONAL ANTIBODIES PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL INSULIN PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL ERYTHROPOIETIN PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL INTERFERON PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL COLONY-STIMULATING FACTOR PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL COAGULATION FACTOR PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL VACCINES PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL OTHER PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
11. GLOBAL PROTEIN ENGINEERING INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL PROTEIN ENGINEERING SERVICES AND SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL PROTEIN ENGINEERING REAGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
15. GLOBAL PROTEIN ENGINEERING IN ACADEMIC RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
16. GLOBAL PROTEIN ENGINEERING IN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
17. GLOBAL PROTEIN ENGINEERING IN CRO MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
18. GLOBAL PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
19. NORTH AMERICAN PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
20. NORTH AMERICAN PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY PROTEIN TYPE, 2021-2028 ($ MILLION)
21. NORTH AMERICAN PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
22. NORTH AMERICAN PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
23. EUROPEAN PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
24. EUROPEAN PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY PROTEIN TYPE, 2021-2028 ($ MILLION)
25. EUROPEAN PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
26. EUROPEAN PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
27. ASIA-PACIFIC PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
28. ASIA-PACIFIC PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY PROTEIN TYPE, 2021-2028 ($ MILLION)
29. ASIA-PACIFIC PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
30. ASIA-PACIFIC PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
31. REST OF THE WORLD PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY PROTEIN TYPE, 2021-2028 ($ MILLION)
32. REST OF THE WORLD PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
33. REST OF THE WORLD PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL PROTEIN ENGINEERING MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL PROTEIN ENGINEERING MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL PROTEIN ENGINEERING DRUGS MARKET, 2021-2028 (%)
4. GLOBAL PROTEIN ENGINEERING MARKET SHARE BY PROTEIN TYPE, 2021-2028 (%)GLOBAL MONOCLONAL ANTIBODIES PROTEIN ENGINEERING MARKET SHARE BY GEOGRAPHY, 2021-2028 ($ MILLION)
5. GLOBAL INSULIN PROTEIN ENGINEERING MARKET SHARE BY GEOGRAPHY, 2021-2028 ($ MILLION)
6. GLOBAL ERYTHROPOIETIN PROTEIN ENGINEERING MARKET SHARE BY GEOGRAPHY, 2021-2028 ($ MILLION)
7. GLOBAL INTERFERON PROTEIN ENGINEERING MARKET SHARE BY GEOGRAPHY, 2021-2028 ($ MILLION)
8. GLOBAL COLONY-STIMULATING FACTOR PROTEIN ENGINEERING MARKET SHARE BY GEOGRAPHY, 2021-2028 ($ MILLION)
9. GLOBAL COAGULATION FACTOR PROTEIN ENGINEERING MARKET SHARE BY GEOGRAPHY 2021-2028 ($ MILLION)
10. GLOBAL VACCINES PROTEIN ENGINEERING MARKET SHARE BY GEOGRAPHY, 2021-2028 ($ MILLION)
11. GLOBAL OTHER PROTEIN ENGINEERING MARKET SHARE BY GEOGRAPHY, 2021-2028 ($ MILLION)
12. GLOBAL PROTEIN ENGINEERING MARKET SHARE BY PRODUCT, 2021 VS2028 (%)
13. GLOBAL PROTEIN ENGINEERING INSTRUMENTS MARKET SHARE BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL PROTEIN ENGINEERING SERVICES AND SOFTWARE MARKET SHARE BY REGION, 2021-2028 ($ MILLION)
15. GLOBAL PROTEIN ENGINEERING REAGENTS MARKET SHARE BY REGION, 2021-2028 ($ MILLION)
16.
17. GLOBAL PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
18. GLOBAL PROTEIN ENGINEERING IN ACADEMIC RESEARCH INSTITUTES MARKET SHARE BY GEOGRAPHY, 2021-2028 ($ MILLION)
19. GLOBAL PROTEIN ENGINEERING IN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET SHARE BY GEOGRAPHY, 2021-2028 ($ MILLION)
20. GLOBAL PROTEIN ENGINEERING IN CRO MARKET SHARE BY GEOGRAPHY, 2021-2028 ($ MILLION)
21. GLOBAL PROTEIN ENGINEERING MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
22. US PROTEIN ENGINEERING MARKET SIZE, 2021-2028 ($ MILLION)
23. CANADA PROTEIN ENGINEERING MARKET SIZE, 2021-2028 ($ MILLION)
24. UK PROTEIN ENGINEERING MARKET SIZE, 2021-2028 ($ MILLION)
25. FRANCE PROTEIN ENGINEERING MARKET, 2021-2028 ($ MILLION)
26. GERMANY PROTEIN ENGINEERING MARKET SIZE, 2021-2028 ($ MILLION)
27. ITALY PROTEIN ENGINEERING MARKET SIZE, 2021-2028 ($ MILLION)
28. SPAIN PROTEIN ENGINEERING MARKET SIZE, 2021-2028 ($ MILLION)
29. REST OF EUROPE DEMENTIA DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
30. INDIA PROTEIN ENGINEERING MARKET, 2021-2028 ($ MILLION)
31. CHINA PROTEIN ENGINEERING MARKET SIZE, 2021-2028 ($ MILLION)
32. JAPAN PROTEIN ENGINEERING MARKET, 2021-2028 ($ MILLION)
33. SOUTH KOREA PROTEIN ENGINEERING MARKET SIZE, 2021-2028 ($ MILLION)
34. REST OF ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, 2021-2028 ($ MILLION)
35. REST OF THE WORLD PROTEIN ENGINEERING MARKET SIZE, 2021-2028 ($ MILLION)
